The store will not work correctly when cookies are disabled.
5-(2-amino-5-benzyloxazol-4-yl)furan-2-ylphosphonic acid
ID: ALA3218214
PubChem CID: 85770095
Max Phase: Preclinical
Molecular Formula: C14H13N2O5P
Molecular Weight: 320.24
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Nc1nc(-c2ccc(P(=O)(O)O)o2)c(Cc2ccccc2)o1
Standard InChI: InChI=1S/C14H13N2O5P/c15-14-16-13(10-6-7-12(20-10)22(17,18)19)11(21-14)8-9-4-2-1-3-5-9/h1-7H,8H2,(H2,15,16)(H2,17,18,19)
Standard InChI Key: PXZIGKNWHFTDQN-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
7.8541 -4.7835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6713 -4.7835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9256 -4.0068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2627 -3.5247 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6039 -4.0068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7032 -3.7553 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
10.3097 -4.3030 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.2904 -3.0418 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.2809 -3.1697 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8266 -3.7546 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5723 -2.9805 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7542 -2.9807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5029 -3.7595 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1666 -4.2380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2731 -2.3202 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.1697 -5.0552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4635 -5.4664 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7559 -5.0594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0502 -5.4699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0529 -6.2880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7671 -6.6937 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4698 -6.2808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 1 2 0
3 6 1 0
6 7 2 0
6 8 1 0
6 9 1 0
5 10 1 0
11 12 2 0
10 11 1 0
12 13 1 0
13 14 1 0
14 10 2 0
12 15 1 0
14 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 320.24 | Molecular Weight (Monoisotopic): 320.0562 | AlogP: 1.91 | #Rotatable Bonds: 4 |
Polar Surface Area: 122.72 | Molecular Species: ACID | HBA: 5 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 1.08 | CX Basic pKa: 1.85 | CX LogP: 0.33 | CX LogD: -2.01 |
Aromatic Rings: 3 | Heavy Atoms: 22 | QED Weighted: 0.63 | Np Likeness Score: -0.09 |
References
1. Dang Q, Kasibthatla SR, Jiang T, Taplin F, Gibson T, Potter SC, van Poelje PD, Erion MD. (2011) Oxazole phosphonic acids as fructose 1,6-bisphosphatase inhibitors with potent glucose-lowering activity, 2 (4): [10.1039/C0MD00269K] |